NCT05269160 2026-02-17
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)
Baylor College of Medicine
Phase 1/2 Terminated
Clinical Trials
7 trialsNCT05190770 2025-12-03
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
NCT03374995 2024-06-11
Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer
Wake Forest University Health Sciences
Phase NA Completed
NCT02234479 2020-03-18
MediHoney for Radiation Dermatitis
University of Maryland, Baltimore
Phase NA Completed
NCT02556632 2017-11-06
Curcumin-II
University of Rochester
Phase 2 Completed
NCT02534129 2017-10-06
Topical Use of Difinsa53â„¢ to Prevent Radiation Dermatitis
ProTechSure Scientific, Inc.
Phase 1/2 Terminated